13.10USD+1.28%Mkt Cap: 1.11B USDP/E: —Last update: 2026-05-26
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap1.11B USD
Enterprise Value1.19B USD
Revenue (TTM)7.61M USD
Gross Profit29.30M USD
Net Income (TTM)-231.96M USD
Revenue/Share0.0980 USD
Last Price13.10 USD
Fiscal Year EndDec 2025
MR QuarterDec 2018
Employees214
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS30233G2093
Valuation
P/E (Trailing)—
P/E (Forward)-4.51
PEG—
EV/EBITDA-4.24
EV/Revenue155.73
P/S140.73
P/B32.27
EPS (TTM)-3.51
EPS (Forward)-2.84
52W Range
5.46056% of range19.11
52W High19.11 USD
52W Low5.460 USD
Profitability
Gross Margin93.41%
Oper. Margin-450.65%
EBITDA Margin0.00%
Profit Margin-739.42%
ROE-75.78%
ROA-63.73%
Growth
Revenue Growth161.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-240.11M USD
CapEx (TTM)3.28M USD
FCF Margin-2215.98%
FCF Yield-15.20%
Net Debt-27.64M USD
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.07
Current Ratio6.66
Quick Ratio5.97
Book Value/Sh0.3960 USD
Cash/Share0.4770 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 9, 2020
Splits
Last Split1:10
Split DateDec 9, 2020
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)37.00 USD
Target Range20.00 USD – 68.00 USD
# Analysts12
Ownership
Shares Out.83.84M
Float75.28M
Insiders3.67%
Institutions110.05%
Short Interest
Short Ratio15.6d
Short % Float17.85%
Short % Out.16.93%
Shares Short14.19M
Short (prev mo.)13.39M
Technical
SMA 5013.48 (-2.8%)
SMA 20013.96 (-6.2%)
Beta1.77
S&P 52W Chg28.31%
Avg Vol (30d)818.02K
Avg Vol (10d)741.70K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—